Glucose-lowering medications and glucose levels as the major determinants of progression of carotid atherosclerosis in middle-aged adults and elders: a community-based prospective study

• Published in: Frontiers in endocrinology (Lausanne) Vol. 15; p. 1425027
• Main Authors: Chou, Chao-Liang, Lu, Shu-Xin, Cheng, Chun-Fang, Wu, Tzu-Wei, Wang, Li-Yu
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2024
• Subjects: Aged; Blood Glucose - analysis; Blood Glucose - metabolism; Carotid Artery Diseases - blood; Carotid Artery Diseases - epidemiology; carotid atherosclerosis; carotid ultrasonography; diabetes mellitus; Disease Progression; Female; Follow-Up Studies; glucose-lowering medications; Humans; Hypoglycemic Agents - therapeutic use; Incidence; Male; Middle Aged; Prospective Studies; prospective study; Risk Factors; carotid atherosclerosis; diabetes mellitus; disease progression; carotid ultrasonography; prospective study; glucose-lowering medications
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2024.1425027

Few prospective studies explored the incidence and determinant of carotid atherosclerosis (CA) progression (CAP). This community-based prospective study focused on the effects of diabetes mellitus (DM) treatments and glucose levels on CAP risks. We followed up a group of 657 CA-positive middle-aged...